The prolactin/growth hormone receptor family: Structure/function relationships

Journal of Mammary Gland Biology and Neoplasia

Volumn 2, Issue 1, 1997, Pages 7-17

  Goffin, Vincent ^a   Kelly, Paul A ^a  

^a INSERM   (France)

Author keywords

Cytokine; Dimerization; Growth hormone; JAK; Prolactin; Receptor; Stat

Indexed keywords

DNA BINDING PROTEIN; GROWTH HORMONE RECEPTOR; JAK2 PROTEIN, HUMAN; JANUS KINASE 2; ONCOPROTEIN; PROLACTIN RECEPTOR; PROTEIN TYROSINE KINASE; STAT3 PROTEIN; STAT3 PROTEIN, HUMAN; TRANSACTIVATOR PROTEIN;

ANIMAL; CHEMISTRY; DIMERIZATION; ENZYME ACTIVATION; HUMAN; PHOSPHORYLATION; PHYSIOLOGY; REVIEW;

ANIMALS; DIMERIZATION; DNA-BINDING PROTEINS; ENZYME ACTIVATION; HUMANS; JANUS KINASE 2; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; PROTO-ONCOGENE PROTEINS; RECEPTORS, PROLACTIN; RECEPTORS, SOMATOTROPIN; STAT3 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS;

EID: 0030621547     PISSN: 10833021     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026313211704     Document Type: Article

References (60)

1. P. A. Kelly, J. Djiane, M. C. Postel-Vinay, and M. Edery (1991). The prolactin/growth hormone receptor family. Endocr. Rev. 12:235-251.
2. G. Baumann (1995). Growth hormone-binding protein: errant receptor or active player? Endocrinology 136:377-378.
3. L. Lesueur, M. Edery, J. Paly, P. A. Kelly, and J. Djiane (1993). Roles of the extracellular and cytoplasmic domains of the prolactin receptor in signal transduction to milk protein genes. Mol. Endocrinol. 7:1178-1184.
4. A. M. De Vos, M. Ultsch, and A. A. Kossiakoff (1992). Human growth hormone and extracellular domain of its receptor: crystal structure of the complex. Science 255:306-312.
5. W. Somers, M. Ultsch, A. M. De Vos, and A. A. Kossiakoff (1994). The X-ray structure of the growth hormone-prolactin receptor complex: receptor binding specificity developed through conformational variability. Nature 372:478-481.
6. A. A. Kossiakoff, W. Somers, M. Ultsch, K. Andow, Y. A. Muller, and A. M. De Vos (1994). Comparison of the intermediate complexes of human growth hormone bound to the human growth hormone and prolactin receptors. Protein Sci. 3:1697-1705.
7. V. Goffin, K. T. Shiverick, P. A. Kelly, and J. A. Martial (1996). Sequence-function relationships within the expanding family of prolactin, growth hormone, placental lactogen and related proteins in mammals. Endocr. Rev. 17:385-410.
8. M. Murakami, M. Narazaki, M. Hibi, H. Yawata, K. Yazukawa, M. Hamaguchi, T. Taga, and T. Kishimoto (1991). Critical cytoplasmic region of the IL-6 signal transducer, gp 130, is conserved in the cytokine receptor family. Proc. Natl. Acad. Sci. U.S.A. 88:11349-11353.
9. F. Bazan (1989). A novel family of growth factor receptors: a common binding domain in the growth hormone, prolactin, erythropoietin and IL-6 receptors, and p75-IL-2 receptor β-chain. Biochem. Biophys. Res. Commun. 164:788-795.
10. J. Finidori and P. A. Kelly (1995). Cytokine receptor signaling through two novel families of transducer molecules: Janus kinases, and signal transducers and activators of transcription. J. Endocrinol. 147:11-23.
11. J. A. Wells (1996). Binding in the growth hormone receptor complex. Proc. Natl. Acad. Sci. U.S.A. 93:1-6.
12. S. H. Bass, M. G. Mulkerrin, and J. A. Wells (1991). A systematic mutational analysis of hormone-binding determinants in the human growth hormone receptor. Proc. Natl. Acad. Sci. U.S.A. 88:4498-4502.
13. V. Goffin, J. A. Martial, and N. L. Summers (1995). Use of a model to understand prolactin and growth hormone specificities. Prot. Eng. 8:1215-1231.
14. P. Duquesnoy, M. L. Sobrier, B. Duriez, F. Dastot, C. R. Buchanan, M. O. Savage, M. A. Preece, C. T. Craescu, Y. Blouquit, M. Goossens, and S. Amselem (1994). A single amino acid substitution in the exoplasmic domain of human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization. EMBO J. 13:1386-1395.
15. I. Gourdou, L. Gabou, J. Paly, A. Y. Kermabon, L. Belair, and J. Djiane (1996). Development of a constitutively active mutant form of the prolactin receptor, a member of the cytokine receptor family. Mol. Endocrinol. 10:45-56.
16. E. Ginsburg and B. K. Vonderhaar (1995). Prolactin synthesis and secretion by human breast cancer cells. Cancer Res. 55:2591-2595.
17. G. Fuh and J. A. Wells (1995). Prolactin receptor antagonists that inhibit the growth of breast cancer cell lines. J. Biol. Chem. 270:13133-13137.
18. 2 bioassay. J. Biol. Chem. 271:16573-16579.
19. L. S. Argetsinger, G. S. Campbell, X. Yang, B. A. Witthuhn, O. Silvennoinen, J. N. Ihle, and C. Carter-Su (1993). Identification of Jak2 as a growth hormone receptor-associated tyrosine kinase. Celt 74:237-244.
20. 2 cells involves tyrosine phosphorylation of the prolactin receptor and its associated tyrosine kinase. J. Biol. Chem. 269:14021-14026.
21. I. Dusanter-Fourt, O. Muller, A. Ziemiecki, P. Mayeux, B. Drucker, J. Djiane, A. Wilks, A. G. Harper, S. Fischer, and S. Gisselbrecht (1994). Identification of Jak protein tyrosine kinases as signaling molecules for prolactin. Functional analysis of prolactin receptor and prolactin-erythroprotein receptor chimera expressed in lymphoid cells. EMBO J. 13:2583-2591.
22. L. S. Smit, D. J. Meyer, N. Billestrup, G. Norstedt, J. Schwartz, and C. Carter-Su (1996). The role of the growth hormone (GH) receptor and Jak1 and Jak2 kinases in the activation of Stats 1, 3, and 5 by GH. Mol. Endocrinol. 10:519-533.
23. C. V. Clevenger and M. V. Medaglia (1994). The protein tyrosine kinase p59fyn is associated with prolactin (PRL) receptor and is activated by PRL stimulation of T-lymphocytes. Mol. Endocrinol. 8:674-681.
24. J. J. Berlanga, J. A. Fresno Vara, J. Martin-Perez, and J. P. Garcia-Ruiz (1995). Prolactin receptor is associated with c-src kinase in rat liver. Mol. Endocrinol. 9:1461-1467.
25. J. J. Lebrun, S. Ali, A. Ullrich, and P. A. Kelly (1995). Proline-rich sequence-mediated JAK2 association to the prolactin receptor is required but not sufficient for signal transduction. J. Biol. Chem. 270:10664-10670.
26. H. Dinerstein, F. Lago, L. Goujon, F. Ferrag, N. Esposito, J. Finidori, P. A. Kelly, and M. C. Postel-Vinay (1995). The proline-rich region of the growth hormone receptor is essential for Jak2 phosphorylation, activation of cell proliferation and gene transcription. Mol. Endocrinol. 9:1701-1707.
27. A. Sotiropoulos, M. Perrot-Applanat, H. Dinerstein, A. Pallier, M. C. Postel-Vinay, I. Finidori, and P. A. Kelly (1994). Distinct cytoplasmic regions of the growth hormone receptor are required for activation of Jak2, mitogen-activated protein kinase, and transcription. Endocrinology 135:1292-1298.
28. L. DaSilva, O. M. Z. Howard, H. Rui, R. A. Kirken, and W. L. Farrar (1994). Growth signaling and Jak2 association mediated by membrane-proximal regions of prolactin receptors. J. Biol. Chem. 269:18267-18270.
29. L. DaSilva, H. Rui, R. A. Erwin, O. M. Zack Howard, R. A. Kirken, M. G. Malabarba, R. H. Hackett, A. C. Lamer, and W. L. Farrar (1996). Prolactin recruits STAT1, STAT3, and STAT5 independent of conserved receptor tyrosines TYR402, TYR476, TYR515, and TYR580. Mol. Cell. Endocrinol. 117:131-140.
30. R. Ren, B. J. Mayer, P. Cichetti, and D. Baltimore (1993). Identification of ten amino acid proline-rich SH3 binding site. Science 259:1157-1161.
31. P. Colosi, K. Wong, S. R. Leong, and W. I. Wood (1993). Mutational analysis of the intracellular domain of the human growth hormone receptor. J. Biol. Chem. 268:12617-12623.
32. L. Goujon, G. Allevato, G. Simonin, L. Paquereau, A. Le Cam, J. Clark, J. H. Nielsen, J. Djiane, M. C. Postel-Vinay, M. Edery, and P. A. Kelly (1994). Cytoplasmic domains of the growth hormone receptor necessary for signal transduction. Proc. Natl. Acad. Sci. U.S.A. 91:957-961.
33. Y. D. Wang and W. I. Wood (1995). Amino acids of the human growth hormone receptor that are required for proliferation and Jak-STAT signaling. Mol. Endocrinol. 9:303-311.
34. 2+ oscillations and gene transcription. Proc. Natl. Acad. Sci. U.S.A. 92:2725-2729.
35. J. J. Lebrun, S. Ali, V. Goffin, A. Ullrich, and P. A. Kelly (1995). A single phosphotyrosine residue of the prolactin receptor is responsible for activation of gene transcription. Proc. Natl. Acad. Sci. U.S.A. 92:4031-4035.
36. Y. D. Wang, K. Wong, and W. I. Wood (1995). Intracellular tyrosine residues of the human growth hormone receptor are not required for the signaling of proliferation or Jak-STAT activation. J. Biol. Chem. 270:7021-7024.
37. J. A. VanderKuur, X. Wang, L. Zhang, G. Allevato, N. Billestrup, and C. Carter-Su (1995). Growth hormone-dependent phosphorylation of tyrosine 333 and/or 338 of the growth hormone receptor. J. Biol. Chem. 270:21738-21744.
38. A. Sotiropoulos, S. Moutoussamy, F. Renaudie, M. Clauss, C. Kayser, F. Gouilleux, P. A. Kelly, and J. Finidori (1996). Differential activation of Stat3 and Stat5 by distinct regions of the growth hormone receptor. Mol. Endocrinol. 10:998-1009.
39. R. H. Hackett, Y. D. Wang, and A. C. Larner (1995). Mapping of the cytoplasmic domain of the human growth hormone receptor required for the activation of JAK2 and Stat proteins. J. Biol. Chem. 270:21326-21330.
40. R. Das and B. K. Vonderhaar (1995). Transduction of prolactin's (PRL) growth signal through both long and short forms of the PRL receptor. Mol. Endocrinol. 9:1750-1759.
41. K. D. O'Neal and L. Y. Yu-Lee (1994). Differential signal transduction of the short, Nb2 and long prolactin receptors. J. Biol. Chem. 269:26076-26082.
42. S. Ali, Z. Chen, J. J. Lebrun, W. Vogel, A. Kharitonenkov, P. A. Kelly, and A. Ullrich (1996). PTP1D is a positive regulator of the prolactin signal leading to β-casein promoter activation. EMBO J. 15:135-142.
43. J. N. Ihle (1996). STATs: Signal Transducers and Activators of Transcription. Cell 84:331-334.
44. N. D. Horseman and L. Y. Yu-Lee (1994). Transcriptional regulation by the helix bundle peptide hormones: growth hormone, prolactin, and hematopoietic cytokines. Endocr. Rev. 15:627-649.
45. S. Gupta, H. Yan, L. H. Wong, S. Ralph, J. Krolewski, and C. Schindler (1996). The SH2 domains of Stat1 and Stat2 mediate multiple interactions in the transduction of INF-α signals. EMBO J. 15:1075-1084.
46. C. Beadling, J. Ng, J. W. Baddage, and D. A. Cantrell (1996). Interleukin-2 activation of STAT5 requires the convergent action of tyrosine kinases and a serine/threonine kinase pathway distinct from the Raf1/ERK2 MAP kinase pathway. EMBO J. 15:1902-1913.
47. P. A. Ram, S. Park, H. K. Choi, and D. J. Waxman (1996). Growth hormone activation of Stal1, Stat3, and Stat5 in rat liver. J. Biol. Chem. 271:5929-5940.
48. F. Gouilleux, H. Wakao, M. Mundt, and B. Groner (1994). Prolactin induces phosphorylation of Tyr694 of Stat5 (MGF), a prerequisite for DNA binding and induction of transcription. EMBO J. 13:4361-4369.
49. F. Gouilleux, C. Pallard, I. Dusanter-Fourt, H. Wakao, L-A. Haldosen, G. Norstedt, D. Levy, and B. Groner (1995). Prolactin, growth hormone, erythropoietin and granulocyte-macrophage colony stimulating factor induce MGF-Stat5 DNA binding activity. EMBO J. 14:2005-2013.
50. A. L-F. Mui, H. Wakao, A-M. O'Farrell, N. Harada, and A. Miyajima (1995). Interleukin-3, granulocyte-macrophage colony stimulating factor and interleukin-5 transduce signals through two STATS homologs. EMBO J. 14:1166-1175.
51. A. V. Kazansky, B. Raught, S. M. Lindsey, Y. F. Wang, and J. M. Rosen (1996). Regulation of mammary gland factor/Stat5a during mammary gland development. Mol. Endocrinol. 9:1598-1609.
52. F. Ferrag, A. Chiarenza, V. Goffin, and P. A. Kelly (1996). Convergence of signaling transduced by PRL/cytokine chimeric receptors on PRL-responsive gene transcription. Mol. Endocrinol. 10:451-460.
53. R. Piccoletti, P. Maroni, P. Bendinelli, and A. Bernelli-Zazzera (1994). Rapid stimulation of mitogen-activated protein kinase of rat liver by prolactin. Biochem. J. 303:429-433.
54. R. A. Erwin, R. A. Kirken, M. G. Malabarba, W. L. Farrar, and H. Rui (1996). Prolactin activates ras via signaling proteins Shc, growth factor receptor bound 2, and Son of Sevenless. Endocrinology 136:3512-3518.
55. G. S. Campbell, L. Pang, T. Miyasaka, A. R. Saltiel, and C. Carter-Su (1992). Stimulation by growth hormone of MAP kinase activity in 3T3-F422A fibroblasts. J. Biol. Chem. 267:6074-6080.
56. L. S. Argetsinger, G. W. Hsu, M. G. Myers Jr., N. Billestrup, M. White, and C. Carter-Su (1995). Growth hormone, interferon-γ, and leukemia inhibitory factor promoted tyrosyl phosphorylation of insulin receptor substrate-1. J. Biol. Chem. 270:14685-14692.
57. M. Ridderstrale and H. Tornqvist (1994). PI-3 kinase inhibitor wortmannin blocks the insulin-like effects of growth hormone in isolated rat adipocytes. Biochem. Biophys. Res. Commun. 203:306-310.
58. A. R. Buckley, P. D. Crowe, and H. Russel (1988). Rapid activation of a proteine kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen. Proc. Natl. Acad. Sci. U.S.A. 85:8649-8653.
59. M. M. Ilondo, P. De Meyts, and P. Bouchelouche (1994). Human growth hormone increases cytosolic free calcium in cultured human IM-9 lymphocytes: a novel mechanism of growth hormone transmembrane signaling. Biochem. Biophys. Res. Commun. 202:391-397.
60. C. J. Ormandy, A. Camus, J. Barra, D. Damotte, B. K. Lucas, H. Buteau, M. Edery, N. Brousse, C. Babinet, N. Binart, and P. A. Kelly. Null mutation of the prolactin receptor gene produces multiple reproductive defects in the mouse (submitted).